English
简体中文
Total: £ 56.28
Published Date: 2025-05-13 | Pages: 75 | Tables: 80 | New Technology
The global market for Dual Isotope Radionuclide Therapy was valued at US$ 7 million in the year 2024 and is projected to reach a revised size of US$ 15.4 million by 2031, growing at a CAGR of 13.0% during the forecast period.
Dual isotope radionuclide therapy is a strategy that uses two different radionuclides to treat diseases (especially cancer) in combination, improving the therapeutic effect and reducing side effects by combining the physical and biological properties of different nuclides. Dual-nuclide therapy represents an important direction in precision radiation medicine, especially for complex or metastatic cancers.
North American market for Dual Isotope Radionuclide Therapy is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Dual Isotope Radionuclide Therapy is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Dual Isotope Radionuclide Therapy in Clinical Trial Stage is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Dual Isotope Radionuclide Therapy include EANM, MSKCC, Peter MacCallum, Bayer, Novartis, Fusion Pharmaceuticals, ITM Isotope Technologies Munich, Actinium Pharmaceuticals, SmartNuclide, Sinotau Pharmaceutical Group, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Dual Isotope Radionuclide Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dual Isotope Radionuclide Therapy.
The Dual Isotope Radionuclide Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Dual Isotope Radionuclide Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Dual Isotope Radionuclide Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
EANM
MSKCC
Peter MacCallum
Bayer
Novartis
Fusion Pharmaceuticals
ITM Isotope Technologies Munich
Actinium Pharmaceuticals
SmartNuclide
Sinotau Pharmaceutical Group
Segment by Type
β⁻ + α
β⁻ + Auger Electrons
α + Integrated Diagnosis and Treatment
Segment by Application
Clinical Trial Stage
Preclinical
Laboratory Proof of Concept
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Dual Isotope Radionuclide Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Dual Isotope Radionuclide Therapy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 β⁻ + α
1.2.3 β⁻ + Auger Electrons
1.2.4 α + Integrated Diagnosis and Treatment
1.3 Market by Application
1.3.1 Global Dual Isotope Radionuclide Therapy Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Clinical Trial Stage
1.3.3 Preclinical
1.3.4 Laboratory Proof of Concept
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Dual Isotope Radionuclide Therapy Market Perspective (2020-2031)
2.2 Global Dual Isotope Radionuclide Therapy Growth Trends by Region
2.2.1 Global Dual Isotope Radionuclide Therapy Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Dual Isotope Radionuclide Therapy Historic Market Size by Region (2020-2025)
2.2.3 Dual Isotope Radionuclide Therapy Forecasted Market Size by Region (2026-2031)
2.3 Dual Isotope Radionuclide Therapy Market Dynamics
2.3.1 Dual Isotope Radionuclide Therapy Industry Trends
2.3.2 Dual Isotope Radionuclide Therapy Market Drivers
2.3.3 Dual Isotope Radionuclide Therapy Market Challenges
2.3.4 Dual Isotope Radionuclide Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Dual Isotope Radionuclide Therapy Players by Revenue
3.1.1 Global Top Dual Isotope Radionuclide Therapy Players by Revenue (2020-2025)
3.1.2 Global Dual Isotope Radionuclide Therapy Revenue Market Share by Players (2020-2025)
3.2 Global Top Dual Isotope Radionuclide Therapy Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Dual Isotope Radionuclide Therapy Revenue
3.4 Global Dual Isotope Radionuclide Therapy Market Concentration Ratio
3.4.1 Global Dual Isotope Radionuclide Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Dual Isotope Radionuclide Therapy Revenue in 2024
3.5 Global Key Players of Dual Isotope Radionuclide Therapy Head office and Area Served
3.6 Global Key Players of Dual Isotope Radionuclide Therapy, Product and Application
3.7 Global Key Players of Dual Isotope Radionuclide Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Dual Isotope Radionuclide Therapy Breakdown Data by Type
4.1 Global Dual Isotope Radionuclide Therapy Historic Market Size by Type (2020-2025)
4.2 Global Dual Isotope Radionuclide Therapy Forecasted Market Size by Type (2026-2031)
5 Dual Isotope Radionuclide Therapy Breakdown Data by Application
5.1 Global Dual Isotope Radionuclide Therapy Historic Market Size by Application (2020-2025)
5.2 Global Dual Isotope Radionuclide Therapy Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Dual Isotope Radionuclide Therapy Market Size (2020-2031)
6.2 North America Dual Isotope Radionuclide Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Dual Isotope Radionuclide Therapy Market Size by Country (2020-2025)
6.4 North America Dual Isotope Radionuclide Therapy Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Dual Isotope Radionuclide Therapy Market Size (2020-2031)
7.2 Europe Dual Isotope Radionuclide Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Dual Isotope Radionuclide Therapy Market Size by Country (2020-2025)
7.4 Europe Dual Isotope Radionuclide Therapy Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Dual Isotope Radionuclide Therapy Market Size (2020-2031)
8.2 Asia-Pacific Dual Isotope Radionuclide Therapy Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Dual Isotope Radionuclide Therapy Market Size by Region (2020-2025)
8.4 Asia-Pacific Dual Isotope Radionuclide Therapy Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Dual Isotope Radionuclide Therapy Market Size (2020-2031)
9.2 Latin America Dual Isotope Radionuclide Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Dual Isotope Radionuclide Therapy Market Size by Country (2020-2025)
9.4 Latin America Dual Isotope Radionuclide Therapy Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Dual Isotope Radionuclide Therapy Market Size (2020-2031)
10.2 Middle East & Africa Dual Isotope Radionuclide Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Dual Isotope Radionuclide Therapy Market Size by Country (2020-2025)
10.4 Middle East & Africa Dual Isotope Radionuclide Therapy Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 EANM
11.1.1 EANM Company Details
11.1.2 EANM Business Overview
11.1.3 EANM Dual Isotope Radionuclide Therapy Introduction
11.1.4 EANM Revenue in Dual Isotope Radionuclide Therapy Business (2020-2025)
11.1.5 EANM Recent Development
11.2 MSKCC
11.2.1 MSKCC Company Details
11.2.2 MSKCC Business Overview
11.2.3 MSKCC Dual Isotope Radionuclide Therapy Introduction
11.2.4 MSKCC Revenue in Dual Isotope Radionuclide Therapy Business (2020-2025)
11.2.5 MSKCC Recent Development
11.3 Peter MacCallum
11.3.1 Peter MacCallum Company Details
11.3.2 Peter MacCallum Business Overview
11.3.3 Peter MacCallum Dual Isotope Radionuclide Therapy Introduction
11.3.4 Peter MacCallum Revenue in Dual Isotope Radionuclide Therapy Business (2020-2025)
11.3.5 Peter MacCallum Recent Development
11.4 Bayer
11.4.1 Bayer Company Details
11.4.2 Bayer Business Overview
11.4.3 Bayer Dual Isotope Radionuclide Therapy Introduction
11.4.4 Bayer Revenue in Dual Isotope Radionuclide Therapy Business (2020-2025)
11.4.5 Bayer Recent Development
11.5 Novartis
11.5.1 Novartis Company Details
11.5.2 Novartis Business Overview
11.5.3 Novartis Dual Isotope Radionuclide Therapy Introduction
11.5.4 Novartis Revenue in Dual Isotope Radionuclide Therapy Business (2020-2025)
11.5.5 Novartis Recent Development
11.6 Fusion Pharmaceuticals
11.6.1 Fusion Pharmaceuticals Company Details
11.6.2 Fusion Pharmaceuticals Business Overview
11.6.3 Fusion Pharmaceuticals Dual Isotope Radionuclide Therapy Introduction
11.6.4 Fusion Pharmaceuticals Revenue in Dual Isotope Radionuclide Therapy Business (2020-2025)
11.6.5 Fusion Pharmaceuticals Recent Development
11.7 ITM Isotope Technologies Munich
11.7.1 ITM Isotope Technologies Munich Company Details
11.7.2 ITM Isotope Technologies Munich Business Overview
11.7.3 ITM Isotope Technologies Munich Dual Isotope Radionuclide Therapy Introduction
11.7.4 ITM Isotope Technologies Munich Revenue in Dual Isotope Radionuclide Therapy Business (2020-2025)
11.7.5 ITM Isotope Technologies Munich Recent Development
11.8 Actinium Pharmaceuticals
11.8.1 Actinium Pharmaceuticals Company Details
11.8.2 Actinium Pharmaceuticals Business Overview
11.8.3 Actinium Pharmaceuticals Dual Isotope Radionuclide Therapy Introduction
11.8.4 Actinium Pharmaceuticals Revenue in Dual Isotope Radionuclide Therapy Business (2020-2025)
11.8.5 Actinium Pharmaceuticals Recent Development
11.9 SmartNuclide
11.9.1 SmartNuclide Company Details
11.9.2 SmartNuclide Business Overview
11.9.3 SmartNuclide Dual Isotope Radionuclide Therapy Introduction
11.9.4 SmartNuclide Revenue in Dual Isotope Radionuclide Therapy Business (2020-2025)
11.9.5 SmartNuclide Recent Development
11.10 Sinotau Pharmaceutical Group
11.10.1 Sinotau Pharmaceutical Group Company Details
11.10.2 Sinotau Pharmaceutical Group Business Overview
11.10.3 Sinotau Pharmaceutical Group Dual Isotope Radionuclide Therapy Introduction
11.10.4 Sinotau Pharmaceutical Group Revenue in Dual Isotope Radionuclide Therapy Business (2020-2025)
11.10.5 Sinotau Pharmaceutical Group Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Dual Isotope Radionuclide Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of β⁻ + α
Table 3. Key Players of β⁻ + Auger Electrons
Table 4. Key Players of α + Integrated Diagnosis and Treatment
Table 5. Global Dual Isotope Radionuclide Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Dual Isotope Radionuclide Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Dual Isotope Radionuclide Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Dual Isotope Radionuclide Therapy Market Share by Region (2020-2025)
Table 9. Global Dual Isotope Radionuclide Therapy Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Dual Isotope Radionuclide Therapy Market Share by Region (2026-2031)
Table 11. Dual Isotope Radionuclide Therapy Market Trends
Table 12. Dual Isotope Radionuclide Therapy Market Drivers
Table 13. Dual Isotope Radionuclide Therapy Market Challenges
Table 14. Dual Isotope Radionuclide Therapy Market Restraints
Table 15. Global Dual Isotope Radionuclide Therapy Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Dual Isotope Radionuclide Therapy Market Share by Players (2020-2025)
Table 17. Global Top Dual Isotope Radionuclide Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dual Isotope Radionuclide Therapy as of 2024)
Table 18. Ranking of Global Top Dual Isotope Radionuclide Therapy Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Dual Isotope Radionuclide Therapy Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Dual Isotope Radionuclide Therapy, Headquarters and Area Served
Table 21. Global Key Players of Dual Isotope Radionuclide Therapy, Product and Application
Table 22. Global Key Players of Dual Isotope Radionuclide Therapy, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Dual Isotope Radionuclide Therapy Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Dual Isotope Radionuclide Therapy Revenue Market Share by Type (2020-2025)
Table 26. Global Dual Isotope Radionuclide Therapy Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Dual Isotope Radionuclide Therapy Revenue Market Share by Type (2026-2031)
Table 28. Global Dual Isotope Radionuclide Therapy Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Dual Isotope Radionuclide Therapy Revenue Market Share by Application (2020-2025)
Table 30. Global Dual Isotope Radionuclide Therapy Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Dual Isotope Radionuclide Therapy Revenue Market Share by Application (2026-2031)
Table 32. North America Dual Isotope Radionuclide Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Dual Isotope Radionuclide Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Dual Isotope Radionuclide Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Dual Isotope Radionuclide Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Dual Isotope Radionuclide Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Dual Isotope Radionuclide Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Dual Isotope Radionuclide Therapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Dual Isotope Radionuclide Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Dual Isotope Radionuclide Therapy Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Dual Isotope Radionuclide Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Dual Isotope Radionuclide Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Dual Isotope Radionuclide Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Dual Isotope Radionuclide Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Dual Isotope Radionuclide Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Dual Isotope Radionuclide Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 47. EANM Company Details
Table 48. EANM Business Overview
Table 49. EANM Dual Isotope Radionuclide Therapy Product
Table 50. EANM Revenue in Dual Isotope Radionuclide Therapy Business (2020-2025) & (US$ Million)
Table 51. EANM Recent Development
Table 52. MSKCC Company Details
Table 53. MSKCC Business Overview
Table 54. MSKCC Dual Isotope Radionuclide Therapy Product
Table 55. MSKCC Revenue in Dual Isotope Radionuclide Therapy Business (2020-2025) & (US$ Million)
Table 56. MSKCC Recent Development
Table 57. Peter MacCallum Company Details
Table 58. Peter MacCallum Business Overview
Table 59. Peter MacCallum Dual Isotope Radionuclide Therapy Product
Table 60. Peter MacCallum Revenue in Dual Isotope Radionuclide Therapy Business (2020-2025) & (US$ Million)
Table 61. Peter MacCallum Recent Development
Table 62. Bayer Company Details
Table 63. Bayer Business Overview
Table 64. Bayer Dual Isotope Radionuclide Therapy Product
Table 65. Bayer Revenue in Dual Isotope Radionuclide Therapy Business (2020-2025) & (US$ Million)
Table 66. Bayer Recent Development
Table 67. Novartis Company Details
Table 68. Novartis Business Overview
Table 69. Novartis Dual Isotope Radionuclide Therapy Product
Table 70. Novartis Revenue in Dual Isotope Radionuclide Therapy Business (2020-2025) & (US$ Million)
Table 71. Novartis Recent Development
Table 72. Fusion Pharmaceuticals Company Details
Table 73. Fusion Pharmaceuticals Business Overview
Table 74. Fusion Pharmaceuticals Dual Isotope Radionuclide Therapy Product
Table 75. Fusion Pharmaceuticals Revenue in Dual Isotope Radionuclide Therapy Business (2020-2025) & (US$ Million)
Table 76. Fusion Pharmaceuticals Recent Development
Table 77. ITM Isotope Technologies Munich Company Details
Table 78. ITM Isotope Technologies Munich Business Overview
Table 79. ITM Isotope Technologies Munich Dual Isotope Radionuclide Therapy Product
Table 80. ITM Isotope Technologies Munich Revenue in Dual Isotope Radionuclide Therapy Business (2020-2025) & (US$ Million)
Table 81. ITM Isotope Technologies Munich Recent Development
Table 82. Actinium Pharmaceuticals Company Details
Table 83. Actinium Pharmaceuticals Business Overview
Table 84. Actinium Pharmaceuticals Dual Isotope Radionuclide Therapy Product
Table 85. Actinium Pharmaceuticals Revenue in Dual Isotope Radionuclide Therapy Business (2020-2025) & (US$ Million)
Table 86. Actinium Pharmaceuticals Recent Development
Table 87. SmartNuclide Company Details
Table 88. SmartNuclide Business Overview
Table 89. SmartNuclide Dual Isotope Radionuclide Therapy Product
Table 90. SmartNuclide Revenue in Dual Isotope Radionuclide Therapy Business (2020-2025) & (US$ Million)
Table 91. SmartNuclide Recent Development
Table 92. Sinotau Pharmaceutical Group Company Details
Table 93. Sinotau Pharmaceutical Group Business Overview
Table 94. Sinotau Pharmaceutical Group Dual Isotope Radionuclide Therapy Product
Table 95. Sinotau Pharmaceutical Group Revenue in Dual Isotope Radionuclide Therapy Business (2020-2025) & (US$ Million)
Table 96. Sinotau Pharmaceutical Group Recent Development
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
Table 100. Authors List of This Report
List of Figures
Figure 1. Dual Isotope Radionuclide Therapy Picture
Figure 2. Global Dual Isotope Radionuclide Therapy Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Dual Isotope Radionuclide Therapy Market Share by Type: 2024 VS 2031
Figure 4. β⁻ + α Features
Figure 5. β⁻ + Auger Electrons Features
Figure 6. α + Integrated Diagnosis and Treatment Features
Figure 7. Global Dual Isotope Radionuclide Therapy Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Dual Isotope Radionuclide Therapy Market Share by Application: 2024 VS 2031
Figure 9. Clinical Trial Stage Case Studies
Figure 10. Preclinical Case Studies
Figure 11. Laboratory Proof of Concept Case Studies
Figure 12. Dual Isotope Radionuclide Therapy Report Years Considered
Figure 13. Global Dual Isotope Radionuclide Therapy Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Dual Isotope Radionuclide Therapy Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Dual Isotope Radionuclide Therapy Market Share by Region: 2024 VS 2031
Figure 16. Global Dual Isotope Radionuclide Therapy Market Share by Players in 2024
Figure 17. Global Dual Isotope Radionuclide Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 18. The Top 10 and 5 Players Market Share by Dual Isotope Radionuclide Therapy Revenue in 2024
Figure 19. North America Dual Isotope Radionuclide Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Dual Isotope Radionuclide Therapy Market Share by Country (2020-2031)
Figure 21. United States Dual Isotope Radionuclide Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Dual Isotope Radionuclide Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Dual Isotope Radionuclide Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Dual Isotope Radionuclide Therapy Market Share by Country (2020-2031)
Figure 25. Germany Dual Isotope Radionuclide Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Dual Isotope Radionuclide Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Dual Isotope Radionuclide Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Dual Isotope Radionuclide Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Dual Isotope Radionuclide Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Dual Isotope Radionuclide Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Dual Isotope Radionuclide Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Dual Isotope Radionuclide Therapy Market Share by Region (2020-2031)
Figure 33. China Dual Isotope Radionuclide Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Dual Isotope Radionuclide Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Dual Isotope Radionuclide Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Dual Isotope Radionuclide Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Dual Isotope Radionuclide Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Dual Isotope Radionuclide Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Dual Isotope Radionuclide Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Dual Isotope Radionuclide Therapy Market Share by Country (2020-2031)
Figure 41. Mexico Dual Isotope Radionuclide Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Dual Isotope Radionuclide Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Dual Isotope Radionuclide Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Dual Isotope Radionuclide Therapy Market Share by Country (2020-2031)
Figure 45. Turkey Dual Isotope Radionuclide Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Dual Isotope Radionuclide Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Dual Isotope Radionuclide Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. EANM Revenue Growth Rate in Dual Isotope Radionuclide Therapy Business (2020-2025)
Figure 49. MSKCC Revenue Growth Rate in Dual Isotope Radionuclide Therapy Business (2020-2025)
Figure 50. Peter MacCallum Revenue Growth Rate in Dual Isotope Radionuclide Therapy Business (2020-2025)
Figure 51. Bayer Revenue Growth Rate in Dual Isotope Radionuclide Therapy Business (2020-2025)
Figure 52. Novartis Revenue Growth Rate in Dual Isotope Radionuclide Therapy Business (2020-2025)
Figure 53. Fusion Pharmaceuticals Revenue Growth Rate in Dual Isotope Radionuclide Therapy Business (2020-2025)
Figure 54. ITM Isotope Technologies Munich Revenue Growth Rate in Dual Isotope Radionuclide Therapy Business (2020-2025)
Figure 55. Actinium Pharmaceuticals Revenue Growth Rate in Dual Isotope Radionuclide Therapy Business (2020-2025)
Figure 56. SmartNuclide Revenue Growth Rate in Dual Isotope Radionuclide Therapy Business (2020-2025)
Figure 57. Sinotau Pharmaceutical Group Revenue Growth Rate in Dual Isotope Radionuclide Therapy Business (2020-2025)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
